about
Myeloid leukemia factor 1 associates with a novel heterogeneous nuclear ribonucleoprotein U-like moleculeA novel technique of serial biopsy in mouse brain tumour modelsPhase I and pharmacokinetic studies of erlotinib administered concurrently with radiotherapy for children, adolescents, and young adults with high-grade glioma.Novel oncogenic PDGFRA mutations in pediatric high-grade gliomas.PTEN signaling in brain: neuropathology and tumorigenesis.Comparative drug screening in NUT midline carcinoma.Hls5 regulated erythroid differentiation by modulating GATA-1 activity.Nonredundant functions for Akt isoforms in astrocyte growth and gliomagenesis in an orthotopic transplantation model.The PTEN/Akt pathway dictates the direct alphaVbeta3-dependent growth-inhibitory action of an active fragment of tumstatin in glioma cells in vitro and in vivo.Transcriptional regulation of the homeobox gene NKX3.1 by all-trans retinoic acid in prostate cancer cells.Medulloblastoma Down Under 2013: a report from the third annual meeting of the International Medulloblastoma Working Group.The case for DNA methylation based molecular profiling to improve diagnostic accuracy for central nervous system embryonal tumors (not otherwise specified) in adults.Ultraviolet radiation suppresses obesity and symptoms of metabolic syndrome independently of vitamin D in mice fed a high-fat diet.A Pre-Clinical Assessment of the Pan-ERBB Inhibitor Dacomitinib in Pediatric and Adult Brain Tumors.Heterogeneous expression of fusidic acid resistance in Staphylococcus aureus with plasmid or chromosomally encoded fusidic acid resistance genes.Unusual paediatric spinal myxopapillary ependymomas: Unique molecular entities or pathological variations on a theme?
P50
Q28512155-33742FA5-6552-4C8C-8E07-271303372E3EQ36342222-002AA4B8-C1D0-443B-8BD0-52968DBC9DF3Q37069238-2D24582B-21B7-4E81-A16A-C6D4E0032C25Q37238690-E602B8E7-AF1B-4EB6-8DC7-72EC7E5E1F8FQ37270423-5748019A-BF91-445D-9152-631456665680Q37632187-6B27E0E5-D8A0-4C7A-976B-242CBCC1A31EQ38295601-3C6918CD-3DF9-4B63-A794-970C6EAC0CACQ39555624-71204FF0-D230-4C4C-B997-B080017C1D14Q40200789-144A198D-9A54-4802-9B87-C6F5A43F0281Q40260280-430CEEA4-DD8E-4BFD-87CB-C4EC394C6BB6Q42739353-83E8C7CB-AC7C-4B20-A421-9A7595780137Q47833819-26A3142B-AFE2-4461-8D6E-ED8D4B474309Q51313735-0CDDA5F0-2770-44B6-8FD5-7CD4257B0765Q52638234-DEEF8339-1ADE-4985-9636-3A9CA432D3DBQ54121645-DB400640-1308-47F4-985B-A2552AF92249Q55457561-3B232E13-2433-4EE0-A364-49661412C9BD
P50
description
researcher ORCID ID = 0000-0003-3554-2769
@en
wetenschapper
@nl
name
Raelene Endersby
@ast
Raelene Endersby
@en
Raelene Endersby
@es
Raelene Endersby
@nl
type
label
Raelene Endersby
@ast
Raelene Endersby
@en
Raelene Endersby
@es
Raelene Endersby
@nl
prefLabel
Raelene Endersby
@ast
Raelene Endersby
@en
Raelene Endersby
@es
Raelene Endersby
@nl
P108
P106
P31
P496
0000-0003-3554-2769